Enable Injections said yesterday that it entered a developmental partnership with Genentech for the Enable enFuse device.
Cincinnati-based Enable’s enFuse is an on-body drug delivery platform containing a drug transfer system compatible with syringes and vial containers. Currently, the enFuse is being developed for subcutaneous delivery of large volumes potentially rising to 50 mL.
The companies intend to combine for multiple molecule development programs with long-term manufacturing and supply arrangements to be made.
Get the full story at our sister site, Drug Delivery Business News.